Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10150611 | 0.90 | TSHR (0.60) | TSHRTHRBMAPTALDH1A1 | |
| SCHEMBL23494026 | 0.90 | TSHR (0.60) | TSHRTHRBMAPTALDH1A1 | |
| SCHEMBL3319370 | 0.89 | TSHR (0.75) | TSHRTHRBMAPTALDH1A1POLB | |
| SCHEMBL20001266 | 0.87 | TSHR (0.72) | TSHRTHRBMAPTALDH1A1POLB | |
| SCHEMBL4526188 | 0.85 | TSHR (0.69) | TSHRTHRBMAPTALDH1A1POLB | |
| SCHEMBL31059270 | 0.85 | TSHR (0.69) | TSHRTHRBMAPTALDH1A1POLB | |
| SCHEMBL28421476 | 0.85 | TSHR (0.47) | TSHRTHRBMAPTALDH1A1FFAR1 | |
| SCHEMBL22549211 | 0.85 | TSHR (0.58) | TSHRTHRBMAPTALDH1A1TDP1 | |
| SCHEMBL11306460 | 0.84 | TSHR (0.53) | TSHRTHRBMAPTALDH1A1 | |
| SCHEMBL28733880 | 0.84 | MAPT (0.50) | TSHRMAPTALDH1A1TDP1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024325-A2 | ALL-ACRYLIC TRIBLOCK AND TETRABLOCK COPOLYMERS HAVING A LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2025-01-30 | — | — | WO | claimed |
| CN-117004327-A | Optical adhesive and preparation method thereof | 苏州桐力光电股份有限公司 | 2023-11-07 | — | — | CN | claimed |
| EP-3824005-B1 | LIQUID WOUND DRESSING COMPOSITION | USTAV MAKROMOLEKULARNI CHEMIE AV CR V V I (CZ) | 2023-02-22 | — | — | EP | claimed |
| EP-3824005-A1 | LIQUID WOUND DRESSING COMPOSITION | Ustav Makromolekularni Chemie AV CR, V. V. I. (CZ) | 2021-05-26 | — | — | EP | claimed |
| CN-107109112-B | Phosphate ester-modified acrylic polyol | 巴斯夫欧洲公司 | 2020-07-03 | — | — | CN | claimed |
| WO-2020015768-A1 | LIQUID WOUND DRESSING COMPOSITION | USTAV MAKROMOLEKULARNI CHEMIE AV CR, V. V. I. (CZ) | 2020-01-23 | — | — | WO | claimed |
| CN-102477264-B | Double-sided adhesive tape | 3M创新有限公司 | 2016-09-07 | — | — | CN | claimed |
| CN-1451371-A | Reformable hair fixing composition contg. (meth) acrylate copolymer | OREAL (FR) | 2003-10-29 | — | — | CN | claimed |
| CN-1369257-A | Hair reformable hair compsns. including acrylic acid series copolymer | OREAL (FR) | 2002-09-18 | — | — | CN | claimed |
| EP-0660849-A1 | FLUOROCHEMICAL POLYMER SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-07-05 | — | — | EP | claimed |
| WO-1994006837-A1 | FLUOROCHEMICAL POLYMER SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-03-31 | — | — | WO | claimed |
| US-4156034-A | COPOLYMER OF ACRYLIC ESTER AND STYRENE DERIVATIVE AS COATING AGENT | HITACHI, LTD. (JP) | 1979-05-22 | — | — | US | claimed |
| US-20250302725-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE PHYSICAL PROPERTIES OF HEALTHY AND DAMAGED HAIR | KEVIN MURPHY GROUP PTY. LTD. (AU) | 2025-10-02 | — | — | US | disclosed |
| EP-4613784-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-20250250223-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-08-07 | — | — | US | disclosed |
| CN-119562975-A | Composition containing ester compound and method for producing same, polymerizable composition, (meth) acrylic polymer, and method for producing same | 三菱化学株式会社 | 2025-03-04 | — | — | CN | disclosed |
| EP-0660849-A1 | FLUOROCHEMICAL POLYMER SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-07-05 | — | — | EP | disclosed |
| WO-1994006837-A1 | FLUOROCHEMICAL POLYMER SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-03-31 | — | — | WO | disclosed |
| US-5204208-A | Mixing at least two toners of different dyes or pigments | XEROX CORPORATION (US) | 1993-04-20 | — | — | US | disclosed |
| US-4156034-A | COPOLYMER OF ACRYLIC ESTER AND STYRENE DERIVATIVE AS COATING AGENT | HITACHI, LTD. (JP) | 1979-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250223-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | MMAB, ADCY8, MAT1A | TSHR 4780/4885THRB 4151/4885MAPT 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.